Home › Funds › Farallon Capital Management › BBNX
Farallon Capital Management position in BBNX
BETA BIONICS INC · Health Care
Latest position (Q2 2026)595.00K sh
Reported value held$9.32M
Portfolio Weight0.04%
First reportedQ1 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 3.33M | $40.79M | New |
| Q2 2025 | 4.20M | $61.21M | Add |
| Q3 2025 | 4.31M | $85.72M | Add |
| Q4 2025 | 4.31M | $131.45M | Hold |
| Q1 2026 | 3.61M | $36.15M | Reduce |
| Q2 2026 | 595.00K | $9.32M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding BBNX
- Vanguard Group 2.22M sh · $67.59M · Q4 2025
- Morgan Stanley 4.27M sh · $66.86M · Q2 2026
- BlackRock Inc 3.34M sh · $52.34M · Q2 2026
- Point72 Asset Management 2.25M sh · $35.33M · Q2 2026
- Geode Capital Management 1.07M sh · $16.82M · Q2 2026
- Millennium Management 956.24K sh · $14.98M · Q2 2026
- Balyasny Asset Management 855.68K sh · $13.41M · Q2 2026
- JPMorgan Chase & Co 703.36K sh · $11.96M · Q2 2026
- Bank of America Corp 546.65K sh · $8.57M · Q2 2026
- Goldman Sachs Group 537.11K sh · $8.42M · Q2 2026
- UBS Group AG 386.62K sh · $6.06M · Q2 2026